Lapides Asset Management’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-131,100
Closed -$1.08M 75
2019
Q2
$1.08M Sell
131,100
-20
-0% -$238 0.5% 51
2019
Q1
$1.87M Buy
131,120
+2,740
+2% +$37.7K 0.71% 44
2018
Q4
$1.47M Sell
128,380
-106,040
-45% -$1.64M 0.6% 46
2018
Q3
$4.69M Sell
234,420
-12,640
-5% -$275K 1.02% 38
2018
Q2
$6.18M Buy
247,060
+4,680
+2% +$113K 1.31% 29
2018
Q1
$6.24M Buy
242,380
+7,700
+3% +$210K 1.37% 29
2017
Q4
$5.98M Sell
234,680
-23,240
-9% -$599K 1.3% 32
2017
Q3
$7.24M Hold
257,920
1.48% 26
2017
Q2
$7.74M Buy
257,920
+1,100
+0.4% +$31.2K 1.5% 24
2017
Q1
$7.65M Buy
256,820
+23,060
+10% +$721K 1.44% 28
2016
Q4
$8.09M Buy
233,760
+93,040
+66% +$3.2M 1.45% 24
2016
Q3
$9.3M Sell
140,720
-300
-0.2% -$18.7K 1.58% 23
2016
Q2
$8M Hold
141,020
1.48% 22
2016
Q1
$8.22M Buy
141,020
+30,160
+27% +$1.6M 1.47% 26
2015
Q4
$6.52M Buy
110,860
+36,960
+50% +$2.18M 1.14% 30
2015
Q3
$4.23M Buy
73,900
+13,540
+22% +$1.09M 0.73% 50
2015
Q2
$5.45M Buy
60,360
+25,540
+73% +$2.21M 0.87% 39
2015
Q1
$3.35M Sell
34,820
-11,660
-25% -$1.08M 0.56% 58
2014
Q4
$4.07M Buy
+46,480
New +$4.01M 0.55% 55

Other funds holding TRIB